Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S0WN
|
||||
Former ID |
DCL000070
|
||||
Drug Name |
Biomed 101
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Renal cancer [ICD9: 140-229, 189; ICD10:C64] | Discontinued in Phase 1 | [521466] | ||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Intarcia Therape.
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H36O7
|
||||
Canonical SMILES |
CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)<br />C)OC)CCC
|
||||
InChI |
1S/C28H36O7/c1-5-8-21-23(13-10-19-11-14-25(28(30)31)35-26(19)21)33-16-7-17-34-24-15-12-20(18(3)29)27(32-4)22(24)9-6-2/h10,12-13,15,25H,5-9,11,14,16-17H2,1-4H3,(H,30,31)
|
||||
InChIKey |
ZVVCSBSDFGYRCB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Leukotriene B4 receptor 1 | Target Info | Binder | [550277] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.